Skip to Content

93 7702 (Glimepiride and Rosiglitazone Maleate 4 mg / 8 mg)

Pill with imprint 93 7702 is Red, Round and has been identified as Glimepiride and Rosiglitazone Maleate 4 mg / 8 mg. It is supplied by Teva Pharmaceuticals USA, Inc..

Glimepiride/rosiglitazone is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. Glimepiride/rosiglitazone 4 mg / 8 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 93 7702

Glimepiride and Rosiglitazone Maleate

Imprint
93 7702
Strength
4 mg / 8 mg
Color
Red
Shape
Round
Availability
Prescription only
Drug Class
Antidiabetic combinations
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA, Inc.
National Drug Code (NDC)
00093-7702

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.